Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of HULTA PHARMA. For more details, see the HULTA PHARMA quarterly results and HULTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 7.45 |
1 Week | % | -5.9 |
1 Month | % | -19.7 |
1 Year | % | 66.4 |
52 week H/L | Rs | 11.2/3.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HULTA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 7 | 8 | 8 | 9 | 10 | |
Low | Rs | 4 | 4 | 4 | 3 | 3 | |
Sales per share (Unadj.) | Rs | 0 | 0.2 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | -0.2 | -0.1 | -0.3 | -0.4 | -0.4 | |
Diluted earnings per share | Rs | -0.2 | -0.1 | -0.3 | -0.4 | -0.4 | |
Cash flow per share (Unadj.) | Rs | -0.2 | -0.1 | -0.3 | -0.4 | -0.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 0.1 | -0.1 | -0.3 | -0.8 | -1.2 | |
Adj. book value per share | Rs | 0.1 | -0.1 | -0.3 | -0.8 | -1.2 | |
Shares outstanding (eoy) | m | 7.45 | 7.45 | 7.45 | 7.45 | 7.45 | |
Price / Sales ratio | x | 0 | 37.9 | 0 | 0 | 0 | |
Avg P/E ratio | x | -36.3 | -41.9 | -20.2 | -13.5 | -15.7 | |
P/CF ratio (eoy) | x | -36.5 | -42.0 | -20.2 | -13.5 | -15.7 | |
Price / Book Value ratio | x | 62.6 | -115.1 | -17.1 | -7.7 | -5.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 41 | 43 | 43 | 44 | 50 | |
Total wages/salary | Rs m | 0 | 1 | 1 | 1 | 1 |
HULTA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 1 | 0 | 0 | 0 | |
Other income | Rs m | 0 | 0 | 1 | 0 | 0 | |
Total revenues | Rs m | 0 | 1 | 1 | 0 | 0 | |
Gross profit | Rs m | -1 | -1 | -3 | -3 | -3 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 1 | |
Profit before tax | Rs m | -1 | -1 | -2 | -3 | -3 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -1 | -1 | -2 | -3 | -3 | |
Gross profit margin | % | 0 | -90.6 | 0 | 0 | 0 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | 0 | -91.1 | 0 | 0 | 0 |
HULTA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 0 | 0 | 0 | 0 | 0 | |
Current liabilities | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net working cap to sales | % | 0 | -5.4 | 0 | 0 | 0 | |
Current ratio | x | 3.5 | 0.8 | 0.4 | 4.3 | 3.6 | |
Inventory Days | Days | 0 | 107 | 0 | 0 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 0 | 0 | 0 | 0 | 0 | |
Share capital | Rs m | 75 | 75 | 75 | 75 | 75 | |
"Free" reserves | Rs m | -74 | -75 | -77 | -80 | -83 | |
Net worth | Rs m | 1 | 0 | -2 | -6 | -9 | |
Long term debt | Rs m | 0 | 1 | 3 | 6 | 10 | |
Total assets | Rs m | 1 | 1 | 0 | 1 | 1 | |
Interest coverage | x | 0 | 0 | -22.4 | -9.2 | -4.8 | |
Debt to equity ratio | x | 0 | -1.7 | -1.1 | -1.1 | -1.1 | |
Sales to assets ratio | x | 0 | 1.9 | 0 | 0 | 0 | |
Return on assets | % | -144.5 | -175.4 | -562.4 | -499.3 | -361.5 | |
Return on equity | % | -173.0 | 273.2 | 84.9 | 56.7 | 35.6 | |
Return on capital | % | -172.9 | -383.3 | -698.1 | -555.8 | -425.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
HULTA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -1 | -1 | -2 | -3 | -3 | |
From Investments | Rs m | 2 | 0 | 0 | 0 | 0 | |
From Financial Activity | Rs m | 0 | 1 | 2 | 4 | 3 | |
Net Cashflow | Rs m | 0 | -0 | -0 | 0 | -0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mohan Swami | COMP SEC: Harshita Sitlani | YEAR OF INC: 1987 | BSE CODE: 531155 | FV (Rs): 10 | DIV YIELD (%): - |
More Construction Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare HULTA PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.